CA3199469A1 - Neuromelanin-sensitive mri and methods of use thereof - Google Patents

Neuromelanin-sensitive mri and methods of use thereof

Info

Publication number
CA3199469A1
CA3199469A1 CA3199469A CA3199469A CA3199469A1 CA 3199469 A1 CA3199469 A1 CA 3199469A1 CA 3199469 A CA3199469 A CA 3199469A CA 3199469 A CA3199469 A CA 3199469A CA 3199469 A1 CA3199469 A1 CA 3199469A1
Authority
CA
Canada
Prior art keywords
neuromelanin
disease
mri
alzheimer
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3199469A
Other languages
English (en)
French (fr)
Inventor
Samuel CLARK
Clifford CASSIDY
Pedro ROSA-NETO
Kenneth WENGLER
Guillermo HORGA HERNANDEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ottawa Institute Of Mental Health Research, University of
Royal Institution for the Advancement of Learning
Columbia University in the City of New York
Research Foundation for Mental Hygiene Inc
Terran Biosciences Inc
Original Assignee
Ottawa Institute Of Mental Health Research, University of
Royal Institution for the Advancement of Learning
Columbia University in the City of New York
Research Foundation for Mental Hygiene Inc
Terran Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ottawa Institute Of Mental Health Research, University of, Royal Institution for the Advancement of Learning, Columbia University in the City of New York, Research Foundation for Mental Hygiene Inc, Terran Biosciences Inc filed Critical Ottawa Institute Of Mental Health Research, University of
Publication of CA3199469A1 publication Critical patent/CA3199469A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Psychiatry (AREA)
  • Developmental Disabilities (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine (AREA)
CA3199469A 2020-11-16 2021-11-16 Neuromelanin-sensitive mri and methods of use thereof Pending CA3199469A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063114304P 2020-11-16 2020-11-16
US63/114,304 2020-11-16
US202063120105P 2020-12-01 2020-12-01
US63/120,105 2020-12-01
US202163277490P 2021-11-09 2021-11-09
US63/277,490 2021-11-09
PCT/US2021/059590 WO2022104288A1 (en) 2020-11-16 2021-11-16 Neuromelanin-sensitive mri and methods of use thereof

Publications (1)

Publication Number Publication Date
CA3199469A1 true CA3199469A1 (en) 2022-05-19

Family

ID=81602654

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3199469A Pending CA3199469A1 (en) 2020-11-16 2021-11-16 Neuromelanin-sensitive mri and methods of use thereof

Country Status (9)

Country Link
US (1) US20230389854A1 (https=)
EP (1) EP4243684A4 (https=)
JP (2) JP2023549712A (https=)
KR (1) KR20230131180A (https=)
AU (1) AU2021377338A1 (https=)
CA (1) CA3199469A1 (https=)
IL (1) IL302831A (https=)
MX (1) MX2023005649A (https=)
WO (1) WO2022104288A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230281804A1 (en) * 2020-07-31 2023-09-07 Koninklijke Philips N.V. Landmark detection in medical images
JP2024510080A (ja) 2021-03-11 2024-03-06 テラン バイオサイエンシズ インコーポレイテッド バイオマーカーを含む撮像データセットのハーモナイゼーションのためのシステム、デバイス及び方法
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
WO2023235766A2 (en) * 2022-05-31 2023-12-07 University Of Ottawa Institute Of Mental Health Research Methods for acquiring and analyzing neuromelanin-sensitive mri
CN117095815B (zh) * 2023-07-20 2025-05-27 中国人民解放军海军军医大学第一附属医院 基于磁共振图像和病理全景扫描切片预测带有同源重组缺陷的前列腺癌患者的系统
CN117078638A (zh) * 2023-08-22 2023-11-17 深圳湾实验室 一种图像处理方法、装置及电子设备
TWI877875B (zh) * 2023-10-31 2025-03-21 中國醫藥大學附設醫院 腦部斷層掃描電腦輔助偵測系統、方法及電腦程式產品
CN117690537B (zh) * 2024-02-04 2024-06-18 中日友好医院(中日友好临床医学研究所) Qsm与脑萎缩、脑连接组关联的跨模态方法及装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288545B1 (en) * 1999-03-22 2001-09-11 General Electric Company Method and apparatus for calibration of RF and gradient field time delays
EP2844143B1 (en) * 2012-05-04 2023-07-19 Emory University Method for imaging and determining information associated with regions of the brain
KR102025356B1 (ko) * 2017-11-17 2019-09-25 울산과학기술원 뇌에 존재하는 철의 시각화를 위한 방법
EP3766042B1 (en) * 2018-03-14 2025-05-07 Emory University Systems and methods for generating biomarkers based on multivariate mri and multimodality classifiers for disorder diagnosis
EP3863505A4 (en) * 2018-10-10 2022-08-17 The Trustees of Columbia University in the City of New York SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR NEUROMELANINSENSITIVE MAGNETIC RESONANCE IMAGING AS A NON-INVASIVE PROXY MEASURE OF DOPAMINE FUNCTION IN THE HUMAN BRAIN
CN111681184B (zh) * 2020-06-09 2023-02-24 复旦大学附属华山医院 一种神经黑色素图像重建方法、装置、设备和存储介质

Also Published As

Publication number Publication date
AU2021377338A9 (en) 2024-09-12
AU2021377338A1 (en) 2023-06-01
EP4243684A1 (en) 2023-09-20
KR20230131180A (ko) 2023-09-12
JP2026066253A (ja) 2026-04-16
WO2022104288A1 (en) 2022-05-19
MX2023005649A (es) 2023-09-27
EP4243684A4 (en) 2025-03-12
IL302831A (en) 2023-07-01
JP2023549712A (ja) 2023-11-29
US20230389854A1 (en) 2023-12-07

Similar Documents

Publication Publication Date Title
US20230389854A1 (en) Neuromelanin-sensitive mri and methods of use thereof
Landin-Romero et al. Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia
US20260007323A1 (en) Neuromelanin-sensitive mri for assessing parkinson's disease
Staffaroni et al. Neuroimaging in dementia
Guzman et al. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment
Okkels et al. Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
Sakakibara et al. MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review
Wilde et al. Longitudinal changes in cortical thickness in children after traumatic brain injury and their relation to behavioral regulation and emotional control
Sabbagh et al. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
Blonder et al. Emotional dysfunction in Parkinson’s disease
Tripathi et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT
Daianu et al. An advanced white matter tract analysis in frontotemporal dementia and early-onset Alzheimer’s disease
Walker et al. Non-Alzheimer’s dementia 2: Lewy body dementias
David et al. New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
US10534052B2 (en) FMRI biomarker of neurodegenerative disease
Tuovinen Investigating BOLD signal variability and its physiological signal sources in Alzheimer's disease, behavioral variant frontotemporal dementia, and schizophrenia
CN116745858A (zh) 神经黑色素敏感性mri及其使用方法
Liu et al. Esketamine combined with sertraline for brain Altered Regional Homogeneity in patients with major depressive disorder: a preliminary study
Borland Advancing the use of brief cognitive tests-establishing norms, clinically relevant changes and predictive models
Meadowcroft et al. 18F-FDG-PET hyperactivity in Alzheimer’s disease cerebellum and primary olfactory cortex
Aye Dual-phase PET imaging in cognitive impairment: an imaging study of amyloid and tau PET as measures of neurodegeneration and protein pathology
Pagulayan Madeleine L. Werhane, David P. Sheppard, Kathleen F. Pagulayan, Mark W. Bondi, and Lisa Delano‐Wood
Eguiguren et al. Misdiagnosis of Frontotemporal Dementia in a Patient With Progressive Supranuclear Palsy: A Case Report and Volumetric Neuroimaging Application
Mieling Functional and structural changes in the progression of Alzheimer's disease: insights from human imaging
VanGilder et al. A preliminary study to evaluate white matter structural correlates of delayed visuospatial memory and one-week motor skill retention in nondemented older adults

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241120

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241128

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241128

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251022

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251022

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20251117

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20251117

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20251118

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20251118

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251118

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251118

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251118

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251119